Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Capital Expenditures Incurred but Not yet Paid

1.5 / 5 stars · 27/93 Roast Me

VYOME HOLDINGS, INC. Capital Expenditures Incurred but Not yet Paid

VYOME HOLDINGS, INC. (HIND) reported Capital Expenditures Incurred but Not yet Paid of $5.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2024-05-15.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2024-05-15

  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-03-31 was $5.00K, a 44.44% decline year-over-year.
  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for the quarter ending 2022-12-31 was -$73.00K.
  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for the quarter ending 2022-09-30 was $70.00K, a 311.76% increase year-over-year.
  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for the quarter ending 2022-06-30 was $0.00.
  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $6.00K, a 20.00% increase from fiscal 2021.
  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $5.00K, a 97.41% decline from fiscal 2020.
  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for fiscal 2020 was $193.00K, a 503.13% increase from fiscal 2019.
  • VYOME HOLDINGS, INC. capital expenditures incurred but not yet paid for fiscal 2019 was $32.00K, a 84.08% decline from fiscal 2018.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 6 monthCapital Expenditures Incurred but Not yet Paid 6 month as first filedCapital Expenditures Incurred but Not yet Paid 9 monthCapital Expenditures Incurred but Not yet Paid 12 monthCapital Expenditures Incurred but Not yet Paid 12 month as first filed
2023-03-31$5.00K
10-Q · filed 2024-05-15
-$68.00K
derived: sum of 2 quarters · filed 2024-05-15
$2.00K
derived: sum of 3 quarters · filed 2024-05-15
$2.00K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$73.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$3.00K
derived: sum of 2 quarters · filed 2024-04-01
-$3.00K
derived: sum of 3 quarters · filed 2024-04-01
$6.00K
10-K · filed 2024-04-01
2022-09-30$70.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$70.00K
derived: sum of 2 quarters · filed 2023-11-09
$79.00K
10-Q · filed 2023-11-09
$16.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
$9.00K
10-Q · filed 2023-08-07
$14.00K
10-Q · filed 2022-08-19
-$54.00K
derived: sum of 3 quarters · filed 2023-08-07
-$37.00K
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$9.00K
10-Q · filed 2023-05-15
-$54.00K
derived: sum of 2 quarters · filed 2023-05-15
-$37.00K
derived: sum of 3 quarters · filed 2023-05-15
-$127.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$63.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
-$46.00K
derived: sum of 2 quarters · filed 2023-04-17
-$136.00K
derived: sum of 3 quarters · filed 2023-04-17
$5.00K
10-K · filed 2023-04-17
2021-09-30$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$73.00K
derived: sum of 2 quarters · filed 2022-11-14
$68.00K
10-Q · filed 2022-11-14
$68.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$90.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19
$51.00K
10-Q · filed 2022-08-19
$51.00K
derived: sum of 3 quarters · filed 2022-08-19
$238.00K
derived: sum of 4 quarters · filed 2022-08-19
2021-03-31$141.00K
10-Q · filed 2022-05-23
$141.00K
derived: sum of 2 quarters · filed 2022-05-23
$328.00K
derived: sum of 3 quarters · filed 2022-05-23
$334.00K
derived: sum of 4 quarters · filed 2022-05-23
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08
$187.00K
derived: sum of 2 quarters · filed 2022-04-08
$193.00K
derived: sum of 3 quarters · filed 2022-04-08
$193.00K
10-K · filed 2022-04-08
$0.00
10-K · filed 2021-03-12
2020-09-30$187.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$193.00K
derived: sum of 2 quarters · filed 2021-11-12
$193.00K
10-Q · filed 2021-11-12
$225.00K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$6.00K
10-Q · filed 2021-08-16
$38.00K
derived: sum of 3 quarters · filed 2021-08-16
$38.00K
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$0.00
10-Q · filed 2020-06-19
$32.00K
derived: sum of 2 quarters · filed 2021-03-12
$32.00K
derived: sum of 3 quarters · filed 2021-03-12
$28.00K
derived: sum of 4 quarters · filed 2021-03-12
2019-12-31$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$32.00K
derived: sum of 2 quarters · filed 2021-03-12
$28.00K
derived: sum of 3 quarters · filed 2021-03-12
$32.00K
10-K · filed 2021-03-12
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$4.00K
derived: sum of 2 quarters · filed 2019-11-08
$0.00
10-Q · filed 2019-11-08
$95.00K
derived: sum of 4 quarters · filed 2020-06-19
2019-06-30-$4.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$0.00
10-Q · filed 2019-07-24
$95.00K
derived: sum of 3 quarters · filed 2020-06-19
$95.00K
derived: sum of 4 quarters · filed 2020-06-19
2019-03-31$4.00K
10-Q · filed 2020-06-19
$99.00K
derived: sum of 2 quarters · filed 2020-06-19
$99.00K
derived: sum of 3 quarters · filed 2020-06-19
$159.00K
derived: sum of 4 quarters · filed 2020-06-19
2018-12-31$95.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$95.00K
derived: sum of 2 quarters · filed 2020-02-27
$155.00K
derived: sum of 3 quarters · filed 2020-02-27
$201.00K
10-K · filed 2020-02-27
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$60.00K
derived: sum of 2 quarters · filed 2019-11-08
$106.00K
10-Q · filed 2019-11-08
$63.00K
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$106.00K
10-Q · filed 2019-07-24
$63.00K
derived: sum of 3 quarters · filed 2019-07-24
$93.00K
derived: sum of 4 quarters · filed 2019-07-24
2018-03-31$46.00K
10-Q · filed 2019-05-10
$3.00K
derived: sum of 2 quarters · filed 2019-05-10
$33.00K
derived: sum of 3 quarters · filed 2019-05-10
$0.00
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$43.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
-$13.00K
derived: sum of 2 quarters · filed 2019-02-22
-$46.00K
derived: sum of 3 quarters · filed 2019-02-22
$83.00K
10-K · filed 2019-02-22
2017-09-30$30.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
-$3.00K
derived: sum of 2 quarters · filed 2018-11-02
$126.00K
10-Q · filed 2018-11-02
$266.00K
derived: sum of 4 quarters · filed 2018-11-02
2017-06-30-$33.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$96.00K
10-Q · filed 2018-08-02
$236.00K
derived: sum of 3 quarters · filed 2018-08-02
$115.00K
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$129.00K
10-Q · filed 2018-05-10
$269.00K
derived: sum of 2 quarters · filed 2018-05-10
$148.00K
derived: sum of 3 quarters · filed 2018-05-10
$269.00K
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$140.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$19.00K
derived: sum of 2 quarters · filed 2018-03-05
$140.00K
derived: sum of 3 quarters · filed 2018-03-05
$140.00K
10-K · filed 2018-03-05
2016-09-30-$121.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$0.00
derived: sum of 2 quarters · filed 2017-11-03
$0.00
10-Q · filed 2017-11-03
2016-06-30$121.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$121.00K
10-Q · filed 2017-08-02
2016-03-31$0.00
10-Q · filed 2017-05-10
2015-12-31$0.00
10-K · filed 2018-03-05
2014-12-31$0.00
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36